Contact
searchSearch
HMP Global
Login

Waldenström Macroglobulinemia Excellence Forum

Waldenström Macroglobulinemia
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Constantine Tam
Interview
FDA Approves Zanubrutinib for Waldenström Macroglobulinemia
09/21/2021
Constantine Tam, MD, MBBS, discusses the clinical results from the phase 3 ASPEN trial that led to the approval of zanubrutinib for the treatment of adult patients with WM.
Constantine Tam, MD, MBBS, discusses the clinical results from the phase 3 ASPEN trial that led to the approval of zanubrutinib for the treatment of adult patients with WM.
Constantine Tam, MD, MBBS,...
09/21/2021
Journal of Clinical Pathways
Christian Buske, MD, Comprehensive Cancer Center and the Institute of Experimental Cancer Research at the University Ulm
Videos
Christian Buske, MD, Discusses Ibrutinib for Treating Patients With WM
08/05/2021
Christian Buske, MD, discusses data surrounding ibrutinib for the treatment of Waldenström macroglobulinemia.
Christian Buske, MD, discusses data surrounding ibrutinib for the treatment of Waldenström macroglobulinemia.
Christian Buske, MD, discusses...
08/05/2021
Journal of Clinical Pathways
BTK Inhibitors for the Treatment of Waldenström Macroglobulinemia
Debates and Roundtables
BTK Inhibitors for the Treatment of Waldenström Macroglobulinemia
06/05/2020
An international panel of experts compare and discuss the 3 different BTK inhibitors active in the treatment of Waldenström macroglobulinemia.
An international panel of experts compare and discuss the 3 different BTK inhibitors active in the treatment of Waldenström macroglobulinemia.
An international panel of...
06/05/2020
Oncology
Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia
BLOOD BYTES
Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia
04/24/2020
Steven Treon, MD, PhD, and Christian Buske, MD, discuss recent data surrounding the use of rituximab maintenance for patients with Waldenström macroglobulinemia.
Steven Treon, MD, PhD, and Christian Buske, MD, discuss recent data surrounding the use of rituximab maintenance for patients with Waldenström macroglobulinemia.
Steven Treon, MD, PhD, and...
04/24/2020
Oncology
JCP July-Aug Cover 2025

Current Issue

August 2025
Volume 11
Issue 4
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use